Zepbound (tirzepatide) is a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist that is FDA-approved along with increased physical activity and a reduced-calorie diet for chronic weight management in adults with a starting body mass index (BMI) of: 30 kg/m^2 or higher (obesity) 27 kg/m^2 or higher (overweight) with at least one weight-related condition such as high cholesterol, high blood pressure (hypertension), type 2 diabetes, heart disease, or obstructive sleep apnea
In the present work, liraglutide was acutely administered and DNA was extracted from cecal content
Advanced protocol: Some researchers use up to 2.5 to 3 mg weekly, though evidence supporting additional benefit from higher doses remains limited while side effect potential increases
Peptide therapy is quickly becoming a go-to option for people looking to boost energy, build lean muscle, lose fat, and feel younger
Were open Monday to Saturday, 8am to 7pm